Recruiting Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma NCT07300241 Conditions Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +23 more Locations NEO-811 Los Angeles Site — Duarte, California, United States NEO-811 San Diego Site — San Diego, California, United States NEO-811 Connecticut Site — New Haven, Connecticut, United States NEO-811 Chicago Site — Zion, Illinois, United States View more locations Show fewer locations Loading locations... View Trial Details
Recruiting Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations NCT03786796 Conditions Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more Locations Johns Hopkins Sidney Kimmel Comprehensive Cancer Center — Baltimore, Maryland, United States View Trial Details
Recruiting Systemic Therapy Alone or With Stereotactic Body Radiotherapy for Oligometastatic Kidney Cancer (STROKER Study) NCT06726421 Conditions Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more Locations Union Hospital, Fujian Medical University — Fuzhou, Fujian, China Sun Yat-sen University Cancer Center — Guangzhou, Guangdong, China Union Hospital, Tongji Medical College, Huazhong University of Science and Technology — Wuhan, Hubei, China The First Hospital of Jilin University — Changchun, Jilin, China View more locations Show fewer locations Loading locations... View Trial Details
Completed SBRT (Stereotactic Body Radiation Therapy) in Combination With Nivolumab/Ipilimumab in Renal Cell Carcinoma (RCC) / Kidney Cancer Patients NCT03065179 Conditions Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Cancer, +11 more Locations The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland, United States UT Southwestern — Dallas, Texas, United States View Trial Details
